Ignite Creation Date:
2024-05-06 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05113784
Status:
COMPLETED
Last Update Posted:
2023-09-15
First Post:
2021-09-17
Brief Title:
the Safety and Efficacy of Meplazumab in Patients With COVID-19
Sponsor:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Organization:
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-17
First Submit QC Date:
November 8 2021
Study First Post Date:
2021-11-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-14
Last Update Post Date:
2023-09-15
Last Update Post Date Type:
ACTUAL